Results 221 to 230 of about 690,249 (294)

Relationship between Glasgow Outcome Scale and Neuropsychological Measures after Brain Injury

, 1993
Guy L. Clifton, Jeffrey S. Kreutzer, Sung C. Choi, Catherine W. Devany, Howard M. Eisenberg, Mary A. Foulkes, John A. Jane, Anthony Marmarou, Lawrence F. Marshall   +8 more
openalex   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

Integration of proteomics and bioinformatics in traumatic brain injury biomarker discovery. [PDF]

BioTechnologia (Pozn)
Mohamed MM, El-Absawy EA, Ahmed HM, Hasan ME.   +3 more
europepmc   +1 more source

Immunolocalization of Heat Shock Protein after Fluid Percussive Brain Injury and Relationship to Breakdown of the Blood-Brain Barrier

, 1993
Hirokazu Tanno, Russ P. Nockels, Lawrence H. Pitts, Linda J. Noble‐Haeusslein   +3 more
openalex   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Interleukin-6 and its association with outcome in traumatic brain injury: a prospective cohort. [PDF]

Scand J Trauma Resusc Emerg Med
Cáceres E, Divani AA, Olivella-Gomez J, Di Napoli M, Reyes LF.   +4 more
europepmc   +1 more source

Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors.

, 1993
P Vaughan, Dennis D. Cunningham
openalex   +1 more source

Evolution of Ocular Organ‐On‐Chip Systems for Disease Modelling and Drug Testing: Where are We Now?

Advanced Therapeutics, EarlyView.
The rise in ophthalmic diseases due to aging, screen use, and environmental factors has driven demand for better ocular models. Traditional systems fall short, encouraging the development of organ‐on‐chip devices. These microfluidic platforms replicate eye tissue architecture, enable drug screening, and simulate ocular diseases.
Sara Trujillo
wiley   +1 more source

Disorders of Consciousness, Language and Communication Following Severe Brain Injury. [PDF]

Psychol Belg
Aubinet C, Gillet A, Regnier A.
europepmc   +1 more source

(S)-emopamil protects against global ischemic brain injury in rats.

, 1990
Binshan Lin, W. Dalton Dietrich, Raul Busto, M. D. Ginsberg   +3 more
openalex   +1 more source